Case 5

Clinical and Experimental Dermatology

Volumn 28, Issue 3, 2003, Pages 343-344

  Karim, A ^a   Black, M M ^a   Lawlor, F ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Intravenous immunoglobulins; Scleromyxoedema

Indexed keywords

COLLAGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LAMBDA CHAIN; MELPHALAN; MUCIN;

ADULT; ARTICLE; CASE REPORT; ELECTROPHORESIS; FEMALE; HUMAN; PRIORITY JOURNAL; SCLEROMYXEDEMA; SKIN BIOPSY; TOXICITY; ERYTHEMA; MIDDLE AGED; MYXEDEMA;

ERYTHEMA; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MIDDLE AGED; MYXEDEMA;

EID: 0038115468     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2003.01289.x     Document Type: Article

References (6)

1. Yaron M, Yaron I, Yust I et al. Lichen myxedematosus (scleromyxedema) serum stimulates hyaluronic acid and prostaglandin E production by human fibroblasts. J Rheumatol 1985; 12: 171-5.
2. Dineen AM, Dicken CH. Scleromyxedema. J Am Acad Dermatol 1995; 33: 37-43.
3. Rongioletti F, Hazini A, Rebora A. Coma associated with scleromyxoedema and interferon alfa therapy. Full recovery after steroids and cyclophosphamide combined with plasmapheresis. Br J Dermatol 2001; 144: 1283-4.
4. Harman KE, Abbs IC, Mahood JM et al. Scleromyxoedema and thrombotic, thrombocytopaenic purpura: two rare conditions both responding to plasma exchange. J Eur Acad Dermatol Venereol 1998; 11: 59-65.
5. Feasel AM, Donato ML, Duvic M. Complete remission of scleromyxedema following autologous stem cell transplantation. Arch Dermatol 2001; 137: 1071-2.
6. Lister RK, Jolles S, Whittaker S et al. Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg). J Am Acad Dermatol 2000; 43: 403-8.